1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Biomarker - 50 Global Experts R&D Centers Profiles

Biomarker - 50 Global Experts R&D Centers Profiles

  • March 2015
  • -
  • Expernova
  • -
  • 251 pages

A biomarker is a measurable indicator of whether a biological process is normal or not.
An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule in the urine.
It can be used for medical testing, diagnosis, assessing treatment response or relapse after treatment and molecule toxicity.


Our selection of worldwide scientific and industrial experts, and academic research centers that can be derived of public research institutes or large companies.

For each player you will have a competency profile updated at time of order, a selection of focused work and a presentation of its network partners.

These profiles of expertise provide you with a rapid overview of experts and labs works in R&D, allowing you to evaluate their collection of scientific works and identify the most competent partner for your project.


Profile packs are generated and updated with the unique mapping technology developed by Expernova. Expernova data base is constantly growing, so each profile pack updated at any given time is potentially different from the others profile packs generated at other times on the same subject.

SCOPE OF THE PACK
biological marker, biological sample, alzheimer disease, lung cancer, cancer biomarker, novel biomarker, breast cancer, expression level, prostate cancer, ovarian cancer, protein biomarker, colorectal cancer, prognostic biomarker, renal injury, nucleic acid

EACH EXPERT PROFILE IS COMPOSED OF:


1: General Information

• Name, directions, geolocation,

• Main areas of expertise,

• Its targeted resources


2: Scientific publications

• Type,

• Year of publication,

• Abstract,

• Authors name,

• Source URL (to get the full document),


3: Collaborations Analysis

• Collaborators typology,

• Type of players (Public, Private)

• Top partners (broadly) with co-works and co-concepts

• Top partners (collaborations on the subject of the panorama) with co-works and co-concepts



EACH R&D LAB PROFILE IS COMPOSED OF:

1: General Information

• Name, directions, geolocation,

• Main areas of expertise,

• Its targeted resources


2: Scientific publications

• Type,

• Year of publication,

• Abstract,

• Authors name,

• Source URL (to get the full document),


3: Experts & Documents

• Expert’s name,

• Its 3 best documents on the subject

• Source URL of the documents


4: Collaborations Analysis

• Collaborators typology,

• Type of players (Public, Private)

• Top partners (broadly) with co-works and co-concepts

• Top partners (collaborations on the subject of the panorama) with co-works and co-concepts

Table Of Contents

Biomarker - 50 Global Experts RandD Centers Profiles
I. Selection of key-profiles of innovative companies

1. 30 Experts profiles

2. 20 RandD Labs profiles


APPENDIX

- Experts Index

- RandD Labs index


View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Next Generation Cancer Diagnostics Market Analysis & Trends – Function (Cancer Screening), Application (Biomarker Development, Genetic Analysis), Cancer Type (Lung Cancer and Blood-born cancers),Technology (Next Generation Sequencing) - Forecast to

Global Next Generation Cancer Diagnostics Market Analysis & Trends – Function (Cancer Screening), Application (Biomarker Development, Genetic Analysis), Cancer Type (Lung Cancer and Blood-born cancers),Technology (Next Generation Sequencing) - Forecast to

  • $ 4200
  • Industry report
  • November 2016
  • by Accuray Research LLP

The Global Next Generation Cancer Diagnostics Market is poised to grow at a CAGR of around 28.6% over the next decade to reach approximately $44.6 million by 2025. Some of the prominent trends that the ...

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • September 2016
  • by Global Data

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" ...

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • September 2016
  • by Global Data

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.